News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
636,776 Results
Type
Article (20207)
Company Profile (201)
Press Release (615954)
Multimedia
Podcasts (55)
Webinars (13)
Section
Business (211396)
Career Advice (707)
Deals (31885)
Drug Delivery (50)
Drug Development (64209)
Employer Resources (57)
FDA (13382)
Job Trends (11688)
News (299652)
Policy (23108)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (1518)
Accelerated approval (32)
ADA (26)
Adcomms (2)
Allergies (160)
Alliances (47187)
ALS (148)
Alzheimer's disease (1296)
Antibody-drug conjugate (ADC) (414)
Approvals (14108)
Artificial intelligence (711)
ASCO (204)
Autoimmune disease (279)
Automation (61)
Bankruptcy (298)
Best Places to Work (9349)
BIO (51)
BIOSECURE Act (7)
Biosimilars (137)
BioSpace Insights (96)
Biotechnology (137)
Bladder cancer (170)
Brain cancer (50)
Breast cancer (633)
Cancer (4938)
Cardiovascular disease (326)
Career advice (638)
Career pathing (13)
CAR-T (313)
CDC (12)
Celiac Disease (1)
Cell therapy (816)
Cervical cancer (46)
Clinical research (57067)
Collaboration (2071)
Commercialization (3)
Company closure (1)
Compensation (1500)
Complete response letters (41)
COVID-19 (1507)
CRISPR (118)
C-suite (1101)
Cystic fibrosis (114)
Data (7177)
Decentralized trials (2)
Denatured (28)
Depression (123)
Dermatology (76)
Diabetes (456)
Diagnostics (6571)
Digital health (65)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (314)
Drug pricing (24)
Drug shortages (7)
Duchenne muscular dystrophy (201)
Earnings (84647)
Editorial (11)
Employer branding (9)
Employer resources (54)
Events (108492)
Executive appointments (1012)
FDA (16965)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (29)
Funding (1568)
Gene editing (244)
Generative AI (53)
Gene therapy (581)
GLP-1 (501)
Government (1843)
Grass and pollen (4)
Guidances (356)
Healthcare (14453)
Hematology (123)
HIV (71)
Huntington's disease (28)
IgA nephropathy (78)
Immunology and inflammation (140)
Immuno-oncology (72)
Indications (195)
Infectious disease (1790)
Inflammatory bowel disease (161)
Inflation Reduction Act (6)
Influenza (126)
Intellectual property (313)
Interviews (87)
IPO (14985)
IRA (10)
Job creations (2764)
Job search strategy (573)
JPM (22)
Kidney cancer (19)
Labor market (27)
Layoffs (177)
Leadership (8)
Legal (6046)
Licensing (8)
Liver cancer (72)
Longevity (28)
Lung cancer (610)
Lymphoma (347)
Machine learning (56)
Management (20)
Manufacturing (964)
Marketing (10)
MASH (141)
Medical device (13696)
Medtech (13926)
Mergers & acquisitions (18228)
Metabolic disorders (939)
mRNA (194)
Multiple sclerosis (137)
NASH (7)
Neurodegenerative disease (336)
Neuropsychiatric disorders (53)
Neuroscience (2477)
NextGen: Class of 2026 (5063)
Non-profit (2034)
Now hiring (20)
Obesity (306)
Opinion (118)
Ovarian cancer (192)
Pain (210)
Pancreatic cancer (277)
Parkinson's disease (302)
Partnered (26)
Patents (600)
Patient recruitment (692)
Peanut (61)
People (53217)
Pharmaceutical (41)
Pharmacy benefit managers (12)
Phase 1 (18972)
Phase 2 (25435)
Phase 3 (17187)
Pipeline (9378)
Policy (80)
Postmarket research (1731)
Preclinical (8185)
Press Release (69)
Prostate cancer (271)
Psychedelics (10)
Radiopharmaceuticals (316)
Rare diseases (776)
Real estate (4886)
Recruiting (25)
Regulatory (19543)
Reports (27)
Research institute (1588)
Resumes & cover letters (111)
Rett syndrome (47)
RNA editing (19)
RSV (66)
Schizophrenia (117)
Series A (278)
Series B (198)
Service/supplier (6)
Sickle cell disease (76)
Special edition (1)
Spinal muscular atrophy (106)
Sponsored (25)
Startups (3311)
State (2)
Stomach cancer (4)
Supply chain (80)
Tariffs (12)
The Weekly (25)
Vaccines (705)
Venture capital (67)
Weight loss (114)
Women's health (106)
Worklife (4)
Date
Last 7 days (557)
Last 30 days (2008)
Last 365 days (25076)
2026 (16076)
2025 (25190)
2024 (30114)
2023 (34722)
2022 (45177)
2021 (48663)
2020 (45602)
2019 (36325)
2018 (27300)
2017 (27220)
2016 (26234)
2015 (32733)
2014 (27755)
2013 (23737)
2012 (25704)
2011 (26043)
2010 (24896)
Location
Africa (451)
Alabama (88)
Alaska (6)
Arizona (356)
Arkansas (16)
Asia (33553)
Australia (5237)
California (13562)
Canada (3699)
China (1093)
Colorado (595)
Connecticut (533)
Delaware (301)
Europe (63996)
Florida (2050)
Georgia (438)
Hawaii (4)
Idaho (60)
Illinois (1024)
India (85)
Indiana (442)
Iowa (21)
Japan (578)
Kansas (127)
Kentucky (46)
Louisiana (41)
Maine (39)
Maryland (1507)
Massachusetts (9511)
Michigan (399)
Minnesota (751)
Mississippi (6)
Missouri (145)
Montana (31)
Nebraska (19)
Nevada (129)
New Hampshire (89)
New Jersey (3175)
New Mexico (26)
New York (3443)
North Carolina (1647)
North Dakota (10)
Northern California (6743)
Ohio (384)
Oklahoma (23)
Oregon (28)
Pennsylvania (2604)
Puerto Rico (26)
Rhode Island (50)
South America (727)
South Carolina (90)
South Dakota (1)
Southern California (5571)
Tennessee (196)
Texas (2231)
United States (46512)
Utah (423)
Vermont (2)
Virginia (237)
Washington D.C. (52)
Washington State (1094)
West Virginia (3)
Wisconsin (144)
Wyoming (1)
636,776 Results for "paragonix technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Paragonix Technologies LIVERguard® Used in Cross-Country Donor Liver Transplant Case
May 13, 2025
·
3 min read
Genetown
Paragonix Technologies Announces Nationwide Commercial Availability of FDA-Cleared BAROguard™ Donor Lung Preservation System
Paragonix Technologies, Inc. announces the full commercial launch of its next-generation transport device, the BAROguard™ Donor Lung Preservation System.
April 4, 2024
·
4 min read
Press Releases
UCI Health Partner with Sierra Donor Services to Expand Kidney Transplant Opportunities Utilizing Paragonix KidneyVault Preservation Technology
May 29, 2025
·
4 min read
Genetown
Paragonix Technologies Unveils Expansive Organ Procurement Network
Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the launch of a comprehensive network of donor organ procurement, preservation, and transportation services.
November 28, 2023
·
4 min read
Press Releases
Paragonix to Spotlight Breakthrough Research in Solid Organ Transplantation at the 2025 World Transplant Congress
July 28, 2025
·
4 min read
Press Releases
Paragonix Launches Initiative to Increase Donor Lung Utilization
April 24, 2025
·
4 min read
Genetown
Paragonix Unveils PancreasPak™: The World’s First FDA-Cleared Preservation Device for Donor Pancreas Transplantation
Paragonix Technologies, a leader in organ transplant technology, proudly announces the PancreasPak™ Organ Preservation System, the first FDA-cleared device designed to protect and monitor donor pancreases during transportation.
June 27, 2024
·
3 min read
Press Releases
Paragonix Celebrates 100th Kidney Transplant Case with FDA-Cleared KidneyVault™ System
April 22, 2025
·
3 min read
Press Releases
Paragonix Technologies Expands Abdominal Research in GUARDIAN Clinical Registries
October 3, 2024
·
4 min read
Press Releases
Paragonix Technologies Announces First Pediatric Use of BAROguard Lung Preservation System
October 15, 2024
·
3 min read
1 of 63,678
Next
